Highly effective SNP-based association mapping and management of recessive defects in livestock by C. Charlier et al.
Highly effective SNP-based association mapping and
management of recessive defects in livestock
Carole Charlier1, Wouter Coppieters1, Fre´de´ric Rollin2, Daniel Desmecht3, Jorgen S Agerholm4,
Nadine Cambisano1, Eloisa Carta5, Sabrina Dardano6, Marc Dive, Corinne Fasquelle1, Jean-Claude Frennet,
Roger Hanset1,11, Xavier Hubin7, Claus Jorgensen8, Latifa Karim1, Matthew Kent9, Kirsten Harvey5,
Brian R Pearce5, Patricia Simon1, Nico Tama1, Haisheng Nie1,10, Se´bastien Vandeputte2, Sigbjorn Lien9,
Maria Longeri6, Merete Fredholm8, Robert J Harvey5 & Michel Georges1
The widespread use of elite sires by means of artificial
insemination in livestock breeding leads to the frequent
emergence of recessive genetic defects, which cause significant
economic and animal welfare concerns. Here we show that
the availability of genome-wide, high-density SNP panels,
combined with the typical structure of livestock populations,
markedly accelerates the positional identification of genes and
mutations that cause inherited defects. We report the fine-scale
mapping of five recessive disorders in cattle and the molecular
basis for three of these: congenital muscular dystony (CMD)
types 1 and 2 in Belgian Blue cattle and ichthyosis fetalis in
Italian Chianina cattle. Identification of these causative
mutations has an immediate translation into breeding practice,
allowing marker assisted selection against the defects through
avoidance of at-risk matings.
Livestock productivity has improved remarkably over the last 50 years,
to a large extent because of efficient breeding programs rooted in
quantitative genetics. However, although stringent selection increases
profitability, it may cause drastic reductions in effective population
size, particularly when artificial insemination is heavily relied upon.
For example, although the Holstein-Friesian dairy cattle population
numbers several million individuals worldwide, its effective popula-
tion size is in the low hundreds1,2. Because of the accompanying
increase in coancestry and inbreeding, the industry faces regular
outbreaks of recessive defects. For instance, in the 1990s, B14% of
Holstein-Friesian bulls were shown to carry a missense mutation in
gene encoding the leukocyte b2 integrin subunit CD18, causing
bovine leukocyte adhesion deficiency (BLAD). This lethal immuno-
deficiency affectedB0.2% of newborn calves, at an estimated annual
cost in the United States of $5 million3. More recently, B25% of
Holstein-Friesian bulls were estimated to be carriers of a missense
mutation in the gene encoding the Golgi UDP-N-acetylglucosamine
transporter SLC35A3, causing complex vertebral malformation
(CVM)4. Genealogical studies determined that both genetic defects
were likely disseminated in the population by a founder sire of the
modern Holstein-Friesian breed: Carlin-M Ivanhoe Bell3,4. It is crucial
that the breeding industry implement effective strategies to control
such outbreaks. A path toward that goal is to establish surveillance
centers to detect emerging defects and centralize samples of affected
animals that can then be used to map and identify causal mutations.
The ensuing diagnostic markers could then be used to avoid
at-risk matings.
Toward that goal, we collected samples from affected animals for
five emerging defects in four cattle breeds: congenital muscular
dystonia 1 (CMD1), congenital muscular dystonia 2 (CMD2) and
crooked tail syndrome (CTS) in Belgian Blue cattle, renal lipofusci-
nosis (RL) in Holstein-Friesian and Danish Red cattle and ichthyosis
fetalis (IF) in Italian Chianina cattle. All calves with CMD have
episodes of generalized muscle contractures, but careful clinical
examination suggested two distinct phenotypes (CMD1 and
CMD2). Calves affected by CMD1 show impaired swallowing, fatigue
upon stimulation or exercise, and muscle myotonia resulting in an
inability to flex limbs and injurious falling. CMD1 calves usually die
within a few weeks as a result of respiratory complications. CMD2
calves suffer severe episodes of myoclonus upon acoustic or tactile
stimulation and typically die within a few hours of birth. CMD2 is
reminiscent of congenital myoclonus in Hereford cattle caused by a
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nonsense mutation in the gene encoding the a1 subunit of the
inhibitory glycine receptor5. Despite the high incidence of CMD in
Belgian Blue cattle (0.1–0.2%), the distinction between the two forms,
as well as their inherited nature, has remained controversial6. CTS is
an emerging syndrome in Belgian Blue cattle. Affected animals have a
crooked tail and shortened head, growth retardation, extreme muscu-
larity and spastic paresia, although some characteristics show variable
penetrance. CTS is not lethal per se, but
causes substantial economic losses due to
growth retardation and treatment. RL is
characterized by the accumulation of lipofus-
cine granules in secondary lysosomes of renal
proximal tubular epithelial cells, as well as in
macrophages and in the reticular and
endothelial cells of kidney-associated lymph
nodes. Affected animals are identified at
slaughter by their discolored kidneys, justify-
ing the more common designation of ‘black
kidney disease’. RL is not accompanied by
gross renal dysfunction, yet it may cause
more insidious deleterious effects, as evi-
denced by a reduced longevity of affected
animals7,8. The incidence of RL was estimated at 0.44% in Holstein-
Friesian and 2.5% in Danish Red breeds. Genealogical analysis
suggests autosomal recessive inheritance8. Finally, severe forms of IF
have been reported in Chianina cattle. Affected calves show cutaneous
lesions, with deep fissures separating hyperkeratotic skin plaques and
eversion of mucocutaneous junctions (ectropion and eclabium),
reminiscent of harlequin ichthyosis in humans9.
Table 1 Overview of mapping studies
Population Mapping
Defect Breed Casesa Controlsa Log(1/p)b Chrom. Interval Gene
Congenital muscular dystonia 1 (CMD1) Belgian Blue 12 (81) 14 (2,000) 44c 25 2.12 Mb ATPA2A1
Congenital muscular dystonia 2 (CMD2) Belgian Blue 7 (21) 24 (2,000) 44c 29 3.61 Mb SLC6A5
Ichthyosis fetalis (IF) Chianina 3 (3) 9 (96) 3.30d 2 11.78 Mb ABCA12
Crooked tail syndrome (CTS) Belgian Blue 8 (36) 14 (2,000) 44c 19 2.42 Mb –
Renal lipofuscinosis (RL) Holstein Friesian Danish Red 6 (16) 6 (27) 24 (141) 14 44c 17 0.87 Mb –
aNumbers correspond to sample sizes used to perform the genome-wide scan, whereas the numbers in brackets correspond to the total number of samples available. bHighest genome-wide log(1/p)
value obtained using either ASSHOMc or ASSISTd. –, gene not known.
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Figure 1 Congenital muscular dystonia 1
(CMD1). (a) Results of genome-wide association
mapping of the CMD1 mutation with 12 affected
animals and 14 controls using ASSHOM (red)
and ASSIST (blue). The black horizontal bars
mark the limits between the 29 autosomes.
Evidence for linkage (y axis) is measured as
log(1/p), with p being determined by 10,000
locus (ASSHOM) or phenotype (ASSIST)
permutations (see Methods). (b) Genotypes of
cases and controls for SNPs on chromosome 25.
Homozygous genotypes are shown in yellow or
white, and heterozygous genotypes in red.
Overlapping blocks of extended homozygosity in
the cases are marked in black and gray. The
limits and size of the haplotype that is shared
homozygous and identical by state among all
cases is highlighted in red. (c) Above, partial
gene content of the shared chromosome segment,
focusing on the studied candidate genes involved
in neuromuscular physiology. Middle, exonic
composition of the fetal and adult forms of
ATP2A1 highlighting exon 14, which harbors the
mutation encoding R559C. Below, bovine
sequence and interspecies alignments of the
region flanking R559C, showing the extreme
conservation of the Arg559 residue.
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We performed genome-wide SNP scans on DNA samples from
affected individuals and controls (Table 1), using either the 25K
Affymetrix SNP panel or a custom-made 60K Illumina panel
(Supplementary Table 1 and Supplementary Fig. 1 online). The latter
was assembled from SNPs in the public domain obtained from the
Bovine Genome Project of the Human Genome Sequencing Center at
Baylor College of Medicine and from comparing publicly available
BAC end sequences with the bovine reference sequence (W. Coppieters
et al., unpublished data). The assumed order of the SNP markers was
based on build 4.0 of the Bos taurus genome. (See Methods for URLs
for these data sources.) To map the corresponding disease loci, we
developed two heuristic programs detecting overlapping, unusually
long, homozygous chromosome segments among affected cattle. The
first program (ASSHOM) performs homozygosity mapping by search-
ing for shared segments of homozygosity that need not be identical by
state (IBS)10. The second program (ASSIST) performs autozygosity
mapping by searching for shared homozygous and IBS chromosome
segments among affected cattle. Unique, genome-wide significant
signals (P r 0.0005) were readily obtained with one or both
approaches for CMD1 (BTA25), CMD2 (BTA29), CTS (BTA19), RL
(BTA17) and IF (BTA2). These results validated the genetic etiology of
the five defects and confirmed that CMD1 and CMD2 have distinct
determinants. Closer examination of the autozygous segments defined
critical regions of 2.12, 3.61, 2.42, 0.87 and 11.78 Mb for CMD1,
CMD2, CTS, RL and IF, respectively (Table 1, Fig. 1 and Supple-
mentary Figs. 2–5 online). The 0.87-Mb interval for RL corresponds
to a chromosomal segment at which all affected cattle (Holstein-
Friesian and Red Danish) are homozygous for the same haplotype.
This observation suggests that RL is allelically homogeneous across
these breeds, and illustrates the potential gain in mapping resolution
from studying the same trait across breeds, as was recently shown
in the dog11.
The 2.12-Mb segment encompassing the CMD1 locus on bovine
chromosome 25 encompasses 95 transcriptional units, of which 6 were
plausible candidates because their protein products are known to have
functions in neuromuscular physiology (Fig. 1). RT-PCR analyses in
brain, spinal cord and skeletal muscle of affected individuals (cases)
and controls did not reveal any striking alterations in gene expression
for these genes. However, DNA sequencing revealed a missense
mutation (C1676T) leading to a R559C substitution in exon 14 of
ATP2A1, which encodes a fast-twitch skeletal-muscle Ca2+ ATPase.
ATP2A1 (also known as SERCA1) is responsible for pumping Ca2+
from the cytosol back into the sarcoplasmic reticulum, thereby
inducing muscle relaxation12. Nonsense and splice-site mutations in
the human ATP2A1 gene cause Brody myopathy (OMIM 601003), a
rare autosomal recessive disorder characterized by exercise-induced
muscle cramps and impaired muscle relaxation13,14. Arg559 in bovine
ATP2A1 is located within the nucleotide-binding domain and is a
highly conserved, functionally significant residue that directly interacts
with the b-phosphate moiety of ATP (Fig. 1)15. Site-directed muta-
genesis of this residue abolished ATP2A1 function15. Genotyping
2,000 unaffected Belgian Blue animals for the R559C variant did not
reveal a single individual homozygous for the Cys559-encoding
mutation despite a frequency of the Cys559 allele of 0.075 (P ¼
(1 – 0.0752)2,000 ¼ 1.26  105), whereas all 81 confirmed CMD1
cases were homozygous for the mutation. Taken together, these results
strongly suggest that the R559C substitution is causative for CMD1,
disrupting ATP2A1 function by impairing ATP binding.
The 3.61-Mb segment containing the CMD2 locus on bovine
chromosome 29 encompasses 13 genes, including one strong candi-
date: SLC6A5, encoding the Na+/Cl–-dependent glycine transporter
(GlyT2), which is responsible for maintaining an abundant pre-
synaptic pool of neurotransmitter at glycinergic synapses (Supple-
mentary Fig. 2)16. In humans, missense, nonsense and frameshift
mutations in SLC6A5 underlie autosomal recessive hyperekplexia
(OMIM 149400), which is characterized by an exaggerated startle
response to tactile or acoustic stimuli resulting in muscle hypertonia
and life-threatening neonatal apnea episodes17, symptoms highly
reminiscent of CMD2 in Belgian Blue cattle. Sequencing SLC6A5 in
CMD2 cases revealed a missense mutation (T809C) in exon 4,
resulting in a L270P substitution in the third membrane-spanning
domain of GlyT2. Although the Leu270 residue is not predicted to be
involved in glycine or Na+ binding17, a leucine residue is conserved at
this position in all vertebrates studied, indicative of structural and
functional importance (Fig. 2a,b). We did not find a single individual
homozygous for the Pro270-encoding mutation among 2,000 unaf-
fected Belgian Blue animals, despite a frequency of 0.023 for the
Pro270 allele, whereas all 21 confirmed CMD2 cases were homozygous
for the Pro270-encoding allele (P ¼ (1 – 0.0232)2,000 ¼ 0.35). We
introduced the corresponding mutation (affecting Leu269 in human
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Figure 2 Congenital muscular dystonia 2 (CMD2). (a) Sequence of bovine GlyT2 protein highlighting the 12 membrane-spanning domains (TM1–12), the
predicted Na+ (blue triangles) and glycine (black circles) binding residues and the L270P mutation (black shading). (b) Sequence alignment of TM3 showing
its remarkable conservation down to amphibians and fish, including the Leu270 residue. MUT, L270P mutant; WT, wild type. (c) Confocal images of
transfected HEK293 cells showing membrane localization of myc-hGlyT2 and the myc-hGlyT2L269P mutant counterstained with the nuclear marker
TOPRO3. (d) Glycine uptake in HEK293 cells transiently transfected with pRKmyc-hGlyT2 and the pRKmyc-hGlyT2L269P mutant after 5 min incubation
with 200 mM [3H]glycine. Data are means ± s.e.m. (n ¼ 6–20). Statistical comparisons were made using an unpaired Student’s t-test. *, significantly
different from vector control.
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GlyT2) into the expression construct pRK5myc-hGlyT2 (ref. 17) by
site-directed mutagenesis, and analyzed two independent mutant
constructs for subcellular localization and [3H]glycine uptake in
HEK293 cells. Consistent with the effect of most missense mutations
in human GlyT2 (ref. 17), this substitution did not affect membrane
trafficking, but abolished [3H]glycine uptake (Fig. 2c,d). Taken
together, these results demonstrate that the L270P mutation is
causative for CMD2 and disrupts presynaptic uptake of glycine
by GlyT2.
The three IF cases available were closely related; hence, the shared
segment on bovine chromosome 2 containing the IF mutation was
large, 11.78 Mb (Supplementary Fig. 3). However, we noted that the
orthologous region on human chromosome 2 contains ABCA12,
which encodes an ATP-binding cassette (ABC) transporter found in
the lamellar granules of keratinocytes, where it is thought to have an
important role in the regulation of lipid trafficking18. Missense
mutations in the first ATP-binding domain of human ABCA12
cause lamellar ichthyosis type 2 (ref. 19), whereas nonsense, frameshift
and in rare cases missense mutations have been shown to cause the
more severe harlequin ichthyosis (OMIM 242500)20–24, which mark-
edly resembles IF. We therefore sequenced ABCA12 in the affected
cases and controls and identified a missense mutation in exon 39
(A5804G) resulting in an H1935R substitution in the fourth extra-
cellular loop. The corresponding His1935 residue is conserved in the
ABCA12 ortholog of all sequenced vertebrates (including amphibians
and fish) as well as in 7 of the 11 human ABCA transporters,
underlining its key structural and functional importance (Fig. 3).
Genotyping 96 healthy Chianina cattle identified two individuals
that were heterozygous for the His1935- and the Arg1935-encoding
alleles, whereas the three IF cases were homozygous for the Arg1935-
encoding allele. The Arg1935 allele was not found in other breeds
(n ¼ 60). Again, these findings support the disease causality of the
H1935R mutation.
We have shown that using SNP arrays with a marker density on the
order of one SNP per 55 kb allows highly effective localization of
mutations causing inherited defects in livestock. It is noteworthy that
neither CMD2, RL nor IF could be mapped by linkage analysis or
association studies using a panel of 400 microsatellite markers and the
available pedigree material (data not shown). Moreover, we show that,
after having determined the map location, it is possible to rapidly
identify the causal mutations in a substantial proportion of cases.
Indeed, we have located the genes and mutations responsible for
CMD1 (ATP2A1) and CMD2 (SLC6A5) in Belgian Blue cattle, and for
ichthyosis fetalis (ABCA12) in Italian Chianina, defining new missense
mutations that disrupt protein function and identifying the corre-
sponding human disorders (Brody myopathy, hyperekplexia and
harlequin ichthyosis). The 2.42- and 0-87 Mb intervals encompassing
the mutations causing CTS and RL are presently being screened
to identify the corresponding causative mutations (Supplementary
Figs. 4 and 5).
These advances have important practical consequences, as they
allow the rapid control of emerging recessive defects with otherwise
major economic and animal welfare implications. This is well illu-
strated by the fact that the diseases CMD1 and CMD2 were essentially
eliminated from the Belgian Blue breed within a matter of months
after the discovery of the causal mutations. Virtually all artificial
insemination sires were genotyped for both defects (revealing that
B11.4% were carriers of CMD1, 4.6% of CMD2 and 0.6% of both, in
good agreement with reported CMD incidence) and the genotypes
published. The test was offered to breeders, allowing them to test
their cows and private bulls and combine the information to avoid
at-risk matings. Carrier animals are not systematically culled, as
their overall breeding worth may outweigh the economic penalty of
carrier status.
Domestic animal populations are a treasure trove of inherited
phenotypic variability as the result of centuries of selection for
useful or fashionable attributes. Our work, as well as comparable
results obtained in dogs11 and undoubtedly soon to be obtained
in other species, shows that the analysis of domestic animal
populations has the potential to make an extremely valuable con-
tribution toward unraveling genotype-phenotype relationships and
genome function.
METHODS
Genotyping. Genotyping using the custom-made 60K iSelect panel as well as
the 25K Affymetrix array was performed using standard procedures as
recommended by the respective manufacturers. CMD1, CTS, RL and IF cases
and controls were genotyped with the Illumina 60K panel, whereas CMD2 cases
were genotyped with the Affymetrix 25K panel.
Association analysis. ASSHOM first scans the genome of each of the N studied
cases for blocks of adjacent homozygous markers. Markers within such blocks
receive a score sij corresponding to the sum of –log(pi
2) over all markers in the
block. In this, pi is the frequency (estimated in controls) of the allele for which
case i is homozygous and j is the marker number (out of M markers). Thus, the
longer and rarer the homozygous haplotype, the higher the score. All markers
-COOH
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Figure 3 Ichthyosis fetalis (IF). (a) Cutaneous lesions and eversion
of mucocutaneous junctions in a Chianina IF case. (b) Schematic
representation of the structure of the ABCA12 protein showing the position
of the transmembrane helices (green) and the nucleotide-binding domains
(blue). The position of the H1935R substitution associated with IF in
Chianina cattle is marked by the red star. The largest extracellular (EC) and
intracellular (IC) loops are numbered. Coordinates are according to ref. 25.
(c) Clustal-W alignments of the amino acid sequences flanking the H1935R
mutation among sequenced vertebrate ABCA12 orthologs and human ABCA
paralogs. MUT, H1935R mutant; WT, wild type.
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for which individual i is heterozygous receive the same 105 score. ASSHOM
then computes a summary score at each marker position, Sj, corresponding to
the harmonic mean of the N corresponding sij scores. If one or more of the
cases are heterozygous at the corresponding marker position, their 105 score
will drastically penalize Sj. The statistical significance of each Sj is estimated
from its rank with respect to a list of ‘best out of M’ Pj scores calculated by
‘locus permutation’. Locus permutation scores Pj are computed as the harmonic
mean of N randomly selected sij scores (one per case). The corresponding
P values are thus corrected for the testing of M marker loci and account for the
level of inbreeding of the cases. ASSIST scans the genome for core markers
defined as polymorphic in controls yet monomorphic in cases. For each
core marker, ASSIST identifies a proximal reference case with the longest
contiguous stretch of homozygous markers proximal from the core, and a distal
reference case with the longest contiguous stretch of homozygous markers
distal from the core. Proximal (or, respectively, distal) scores are then computed
as the sum of –log(pi
2) over contiguous (starting from the core) marker
stretches shared IBS with the proximal (respectively, distal) reference. In this,
pi is the frequency in controls of the allele for which the reference case is
homozygous. Proximal and distal scores are summed to yield an overall score
Sj. Their statistical significances are determined by ‘phenotype permutation’:
disease status is randomly redistributed amongst cases and controls, genome-
wide association conducted with ASSIST and the ‘best out of M’ phenotype
permutation scores Pj scores stored. The P value of real Sjs are then estimated
from their rank with respect to a list of such ‘best out of M’ Pj permutation
scores. ASSIST thus accounts for multiple-marker testing and allelic frequencies
in controls.
Both programs assume that the analyzed trait has simple, monogenic
recessive inheritance (incomplete penetrance is not accommodated). When
samples originating from distinct breeds are analyzed together, ASSHOM
assumes allelic homogeneity within but not necessarily between breeds, whereas
ASSIST assumes allelic homogeneity both within and between breeds.
ASSHOM and ASSIST are available from the authors on request.
Resequencing. For each disease, at least one affected animal and an unrelated
wild-type counterpart, matched for age and breed, were chosen after
careful phenotyping. They were slaughtered following ethical procedures.
Total blood was withdrawn for DNA extraction and tissues samples
were collected directly after the animal’s death, rapidly frozen in liquid nitrogen
and stored at –80 1C until RNA extraction. The tissue panel was disease
specific: skeletal muscle, spinal cord and brain for CMD1 and CMD2; cartilage,
skeletal muscle and spinal cord for CTS; kidney and skeletal muscle for RL; and
skin for IF.
Total RNA was extracted from tissue samples after homogenization in
TRIzol Reagent (Invitrogen) following the manufacturer’s instructions. Total
RNA was ethanol precipitated, resuspended in DEPC-treated water and diluted
at 1 mg/ml. First-strand cDNA was synthesized with the Superscript First-Strand
Synthesis System for RT-PCR (Life Technologies) using a mixture of random
hexamers and oligo(dT) primers. The cDNA was directly amplified by PCR
with gene-specific primers designed to allow full-length ORF amplification.
Primer pairs and PCR conditions for all the positional candidate genes screened
are listed in Supplementary Table 2 online. PCR products were loaded on 1%
agarose gels to compare band intensities and sizes between affected and control
animals. DNA fragments were cut and purified with the GENECLEAN Kit
(Qbiogene). Purified fragments were sequenced using the Big Dye terminator
cycle-sequencing kit (Applied Biosystems). Electrophoresis of purified sequen-
cing reactions was performed on an ABI PRISM 3730 DNA analyzer
(PE Applied Biosystems). Multiple sequence traces from affected and wild-
type animals were aligned and compared using the phredPhrap program from
the Consed package. Pathogenic relevance of each mutation was established by
aligning the protein sequence from available species.
Genomic DNA was extracted from total blood through a standard phenol-
chloroform extraction procedure. Each animal enrolled for the resequencing
study was first genotyped for SNP markers from the minimum genetic interval
to asses its IBD (affected) or non- IBD (wild-type counterpart) status. Finally,
all the available individuals (Table 1) were genotyped for the respective disease
mutations by PCR amplification of the culprit exon followed by resequencing.
Primer pairs for each mutation are listed in Supplementary Table 2.
Functional analysis of GlyT2. [3H]Glycine uptake assays were performed as
described17 in HEK293 cells (ATCC CRL1573) transfected with 0.25 mg total
pRK5myc (vector control), pRK5myc-hGlyT2 or the L269P mutant using
Lipofectamine LTX (Invitrogen). After 24 h, cells were washed with a buffer
containing 116 mM NaCl, 1 mM NaH2PO4, 26 mM NaHCO3, 1.5 mM MgSO4,
5 mM KCl, 1.3 mM CaCl2 and 5 mM glucose pregassed with 5% CO2/95% air
and then incubated for 5 min in 1 mCi/ml [3H]glycine (60 Ci/mmol, NEN) at a
final concentration of 200 mM. Uptake was terminated by two additions of ice-
cold buffer followed by aspiration. Cells were digested in 0.1 M NaOH and used
for scintillation counting and determination of protein concentration using the
Bradford reagent (Bio-Rad). [3H]Glycine uptake was calculated as nmol/min
per mg protein and expressed as a percentage of the pRK5myc-transfected
control. All statistical comparisons used an unpaired Student’s t-test. For GlyT2
immunostaining, transfected cells were washed twice in PBS, fixed for 5 min in
4% (w/v) paraformaldehyde in PBS and quenched in 50 mM NH4Cl for 10 min
before being permeabilized in 0.01% (w/v) Triton X-100, further washed in
PBS and stained with an anti-Myc primary antibody and Alexa Fluor 488–
conjugated secondary antibodies (Invitrogen). Confocal microscopy was per-
formed using a Zeiss Axioscop LSM 510 Meta confocal microscope with 40
objective (NA 1.3) and 3 digital zoom, capturing images at 1,024  1,024–
pixel resolution.
URLs. 25K Affymetrix bovine SNP panel, http://www.affymetrix.com/
products/arrays/specific/bovine.affx; Bovine Genome Project of the Human
Genome Sequencing Center at Baylor College of Medicine, including build 4.0
of the Bos taurus genome, http://www.hgsc.bcm.tmc.edu/projects/bovine/.
Note: Supplementary information is available on the Nature Genetics website.
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